Skip to content

A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF

A Comprehensive Approach To Relief Of Digestive Symptoms In Cystic Fibrosis: CARDS-CF

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05251467
Acronym
CARDS-CF
Enrollment
350
Registered
2022-02-22
Start date
2022-02-28
Completion date
2023-12-03
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis, Digestive System Disease, Genetic Disease, Lung Diseases, Pancreatic Disease, Respiratory Tract Diseases

Keywords

Patient reported outcome measure (PROM), Gastrointestinal symptom burden, Symptom score, Gut, Abdomen

Brief summary

Development of a new patient reported outcome measure (PROM) that will measure the daily burden of gastrointestinal symptoms over the previous 24 hour period for people with cystic fibrosis.

Detailed description

Development of a Patient Reported Outcome Measure (PROM) in line with FDA guidance. The PROM is intended for daily use to measure the symptom burden of gastrointestinal symptoms for people with CF over the last 24 hours. * Development of the initial conceptual framework underpinning the PROM and confirmed through a patient focus group. * Primary item (question) generation for the PROM which will then be refined through a series of interviews with people with CF. * Testing of the items through an online patient questionnaire for testing of frequency, burden and impact of the items. * Piloting testing of the draft PROM daily for 2 weeks via smartphone app. The recall period of the PROM will be gastrointestinal symptom burden over the previous 24 hours. Potential participant's will be identified through 6 UK CF care centres at Nottingham University Hospitals NHS Trust (paediatric and adult CF centres), Leeds Teaching Hospital NHS Trust, Manchester University NHS Foundation trust, Royal Brompton and Harefield NHS Foundation Trust and Kings College Hospital NHS Foundation Trust. In addition, recruitment for the survey and trialing the PROM on a smartphone app will also take place via social media and is therefore also open to people with CF from outside these CF centres.

Interventions

OTHERFocus group

Focus group to confirm PROM conceptual framework

OTHERPatient interview (n = approximately 10)

Patient interviews to refine possible questions for the PROM

OTHERQuestionnaire (n = 180)

Online questionnaire to evaluate the proposed questions as part of PROM development in a larger population

DEVICETesting of the pilot PROM in a smartphone app (n = 150)

Daily testing of the pilot PROM in a smartphone app for 2 weeks

Sponsors

The Leeds Teaching Hospitals NHS Trust
CollaboratorOTHER
Manchester University NHS Foundation Trust
CollaboratorOTHER_GOV
Royal Brompton & Harefield NHS Foundation Trust
CollaboratorOTHER
King's College Hospital NHS Trust
CollaboratorOTHER
Medizinische Hochschule Brandenburg Theodor Fontane
CollaboratorOTHER
Nottingham University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* People with cystic fibrosis age 12 years and over * Confirmed diagnosis of cystic fibrosis based on genotype or sweat chloride testing * Capacity to consent, or to understand the requirements of the study where parental consent is required

Exclusion criteria

* \< 12 years age * Unable to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
To develop a new patient reported outcome measure (PROM) which will measure the daily gastrointestinal symptom burden for people with CF, with a recall period of 24 hours.2 yearsDevelopment of a new PROM following FDA guidance which will measure the daily impact and burden of gastrointestinal symptoms for people with CF. The recall period will be the previous 24 hours. The name of the PROM will be decided as part of the development process. Question development will be iterative. Floor and ceiling effects for each of the questions will be assessed. The CFAbd score will be used to assess construct validity of the newly developed PROM. This will be completed alongside the PROM on days 1 and day 14.

Secondary

MeasureTime frameDescription
Measurement of adherence to daily data capture of the PROM through a smartphone app over a 2 week period2 yearsAdherence data - Percentage of completed PROM days over the 14 day period. Percentage of completed CFabd scores on days 1 and 14. This data will be collated through the research portal feedback facility in the app.
Attrition rate of participants2 yearsAttrition rate over the 2 weeks, define as people completing the app for two weeks (at least 10 out of 14 days) as a percentage of those initially who gave consent to take part and use the app.
Usability of the smartphone app2 yearsUsability of the app - participant feedback via the app on days 7 and 14 to include questions of ease of data entry on the app, whether they experience any technical issues with the app and whether questions are meaningful to participants. These questions will be developed as part of the PROM development process.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026